Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02571959Phase 2Completed
Phase 2, open-label trial of amoxicillin and clavulanic acid in bacterial infection. Primary endpoint: Systematic plasmatic clearance at 1 day. Started Jul 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02571959.